CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
Gilead Sciences, Inc.
(NQ:
GILD
)
55.54
USD
-0.76 (-1.35%)
Streaming Delayed Price
/ Updated:
1:20 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
SEC Filings
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
5,184,994
Open
56.09
Bid (Size)
55.53 (600)
Ask (Size)
55.54 (100)
Prev. Close
56.30
Today's Range
55.50 - 56.78
52wk Range
24.12 - 57.10
Shares Outstanding
1,525,355,825
Dividend Yield
N/A
Top News
More News
Profitable Trading Secrets Revealed in GILD, NWSA, RF and MTG
May 18, 2013
from
Marketwired News Releases
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
May 17, 2013
from
Business Wire News Releases
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story.
Read More
from
StreetInsider.com News Articles
Analyst Moves: NOC, GM, GILD
May 17, 2013
This morning, Credit Suisse increased its price target on shares of Northrop Grumman (NOC) to $78 as additional buybacks will boost the stock. In the report, Credit Suisse also increased its EPS...
Read More
category
Stocks
from
Market News Video
More News
Read More
AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 17, 2013
from
StreetInsider.com News Articles
Lightning Round: Starbucks, Gilead & More
May 16, 2013
category
Lightning Round
,
Starbucks Corp
,
Dominion Resources Inc
, and 10 more.
from
CNBC.com News
Gilead anuncia datos de respuesta del estudio de Fase 2 de idelalisib para leucemia linfática crónica no tratada con anterioridad
May 16, 2013
from
Business Wire Spanish
Strategy Behind Our Success, We Get in Early: GILD, MCP, GM and DF
May 16, 2013
from
Marketwired News Releases
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
category
NYSE:JNJ
,
NYSE:MRK
,
NASDAQ:PCYC
, and 2 more.
from
Forbes Real Time
Gilead Offers Response Data from Phase 2 Study of Idelalisib
May 15, 2013
category
Benzinga
,
News
,
FDA
, and 1 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here